Variability of the QTc interval: impact on defining drug effect and low-frequency cardiac event.
about
Effects of supratherapeutic doses of ebastine and terfenadine on the QT intervalPharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation.Retrospective analysis of cisapride-induced QT changes in end-stage renal disease patients.How does this happen? Part I: mechanisms of adverse drug reactions associated with psychotropic medications.A review of the cardiac systemic side-effects of antihistamines: ebastine.Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT intervalZiprasidone for agitation or psychosis in dementia: four cases.Update on the cardiac safety of moxifloxacin.Clinically relevant QTc prolongation due to overridden drug-drug interaction alerts: a retrospective cohort study.Moxifloxacin does increase the corrected QT interval.Modeling the effects of the circadian clock on cardiac electrophysiology.Valdecoxib, a COX-2-specific inhibitor, does not affect cardiac repolarization.Clinical experience with moxifloxacin in patients with respiratory tract infections.Man versus machine: is there an optimal method for QT measurements in thorough QT studies?Antihistamine activity, central nervous system and cardiovascular profiles of histamine H1 antagonists: comparative studies with loratadine, terfenadine and sedating antihistamines in guinea-pigs.
P2860
Q28345558-B393CF06-C54E-4E9E-91BB-DFE1641F132FQ31026162-CB319FCE-8E63-4B91-B0A8-8E864BD66FD3Q33145870-4648EFE3-54A2-4460-AF1B-737EED222141Q33602939-7E0233EE-6CCA-4942-B3D6-75F714E8A045Q33709836-565BF8A1-BABA-4FD9-85B4-628044834320Q35579763-1CE5E9C1-4D4B-41B3-B5EA-A7F6CECC2227Q36174492-358D5B18-055B-45BA-82F3-EB89EE8EC1E5Q36345861-04819921-72E2-47EB-BEB7-98A5FD890DFCQ37173968-DA3B500D-6CF1-4B69-B820-19EA8CB59DE8Q43743491-6FB10DB1-5296-4F2E-8A20-9A621444FA01Q44561540-7A6EB5F5-2720-4D08-B599-8BE8332F7A17Q44582898-6F785C0A-3786-48F8-A049-C6E17CB0CA5BQ44802983-A5DA1A5F-914E-4897-95E7-3BCB2E2454D1Q47337001-EF13E327-F319-4DF9-BBB7-3164BA762765Q51593052-F5F4199E-ECA6-40FE-91B5-0F77C0379985
P2860
Variability of the QTc interval: impact on defining drug effect and low-frequency cardiac event.
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Variability of the QTc interva ...... d low-frequency cardiac event.
@ast
Variability of the QTc interva ...... d low-frequency cardiac event.
@en
type
label
Variability of the QTc interva ...... d low-frequency cardiac event.
@ast
Variability of the QTc interva ...... d low-frequency cardiac event.
@en
prefLabel
Variability of the QTc interva ...... d low-frequency cardiac event.
@ast
Variability of the QTc interva ...... d low-frequency cardiac event.
@en
P2093
P1476
Variability of the QTc interva ...... d low-frequency cardiac event.
@en
P2093
Lacerda AE
Morganroth J
P304
P356
10.1016/0002-9149(93)90037-D
P407
P577
1993-08-01T00:00:00Z